ANI Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.46 billion, with shareholders equity totaling $637.11 million.
The company employs approximately 1.050 people and operates in the Health sector, within the Pharmaceutical Products industry.
Over the past 12 months, ANI Pharmaceuticals Inc. reported $1.04 billion in revenue, generating net income of $116.84 million.
Key financial metrics include a P/E ratio of 12.46, a price-to-book (P/B) ratio of 2.29, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker ANIP.